Skip to main content

Main menu

  • Home
  • About
    • Clinical Chemistry
    • Editorial Board
    • Most Read
    • Most Cited
    • Alerts
  • Articles
    • Current Issue
    • Early Release
    • Future Table of Contents
    • Archive
    • Browse by Subject
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Advertisers
    • Permissions & Reprints
  • Resources
    • AACC Learning Lab
    • Clinical Chemistry Trainee Council
    • Clinical Case Studies
    • Clinical Chemistry Guide to Scientific Writing
    • Clinical Chemistry Guide to Manuscript Review
    • Journal Club
    • Podcasts
    • Q&A
    • Translated Content
  • Abstracts
  • Submit
  • Contact
  • Other Publications
    • The Journal of Applied Laboratory Medicine

User menu

  • Subscribe
  • My alerts
  • Log in

Search

  • Advanced search
Clinical Chemistry
  • Other Publications
    • The Journal of Applied Laboratory Medicine
  • Subscribe
  • My alerts
  • Log in
Clinical Chemistry

Advanced Search

  • Home
  • About
    • Clinical Chemistry
    • Editorial Board
    • Most Read
    • Most Cited
    • Alerts
  • Articles
    • Current Issue
    • Early Release
    • Future Table of Contents
    • Archive
    • Browse by Subject
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Advertisers
    • Permissions & Reprints
  • Resources
    • AACC Learning Lab
    • Clinical Chemistry Trainee Council
    • Clinical Case Studies
    • Clinical Chemistry Guide to Scientific Writing
    • Clinical Chemistry Guide to Manuscript Review
    • Journal Club
    • Podcasts
    • Q&A
    • Translated Content
  • Abstracts
  • Submit
  • Contact
Article CommentaryClinical Case Study

Commentary

Maya Styner, Nichole Korpi-Steiner
DOI: 10.1373/clinchem.2017.281865 Published January 2018
Maya Styner
Department of Medicine, Division of Endocrinology and Metabolism, University of North Carolina, Chapel Hill, NC;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mstyner@med.unc.edu
Nichole Korpi-Steiner
Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

This case of postgastric bypass osteomalacia, secondary hyperparathyroidism, and resulting pelvic fractures highlights important concepts in bone fragility, as well as the significance of the oft-ordered and poorly understood 25-OH vitamin D. Obesity is well-recognized to be protective against pelvic and hip fractures (1). Although gastric bypass increases the risk for potential bone loss, it is intriguing that this patient had pelvic fractures years after she regained most of her weight, suggesting mechanical unloading was unlikely a major contributor.

The Institute of Medicine recommends a 25-OH vitamin D ≥20 ng/mL as generally adequate for bone health. Post-gastric-bypass patients may require 25-OH vitamin D concentrations much higher than 20 ng/mL to permit appropriate absorption of calcium and phosphorus in the gut. Notably, most post-bypass patients who maintain 25-OH vitamin D concentrations around 30 ng/mL fail to demonstrate a prominent increase in parathyroid hormone (PTH), emphasizing the uniqueness of this case regarding PTH concentrations. Although the iron concentration was low, other nutrients' concentration, including B12 concentration, was normal, underscoring a need to maintain a high suspicion for calcium malabsorption and secondary increase of PTH in such patients.

As with many post-gastric-bypass osteomalacia cases, bone density by dual-energy x-ray absorptiometry (DXA) demonstrates osteopenia, not osteoporosis, and this, combined with patient age of <65 years, typically represents a low fracture risk. However, DXA results often fail to correlate with bone fracture risk in younger patients with secondary causes of fragility or mineralization defects. Moreover, bone loss often occurs rapidly after gastric bypass in multiple skeletal sites (2), and the rate of bone density loss may be more detrimental than the absolute value in increasing bone fragility. In addition to osteomalacia, this patient likely had osteitis fibrosa cystica or brown tumor changes on the basis of high PTH concentrations, which may have existed for a long time and are frequently associated with bone pain.

Footnotes

  • Author Contributions: All authors confirmed they have contributed to the intellectual content of this paper and have met the following 3 requirements: (a) significant contributions to the conception and design, acquisition of data, or analysis and interpretation of data; (b) drafting or revising the article for intellectual content; and (c) final approval of the published article.

  • Authors' Disclosures or Potential Conflicts of Interest: No authors declared any potential conflicts of interest.

  • Received for publication October 5, 2017.
  • Accepted for publication October 10, 2017.
  • © 2017 American Association for Clinical Chemistry

References

  1. 1.↵
    1. Prieto-Alhambra D,
    2. Premaor MO,
    3. Fina Aviles F,
    4. Hermosilla E,
    5. Martinez-Laguna D,
    6. Carbonell-Abella C,
    7. et al
    . The association between fracture and obesity is site-dependent: A population-based study in postmenopausal women. J Bone Miner Res 2012;27:294–300.
    OpenUrlCrossRefPubMed Order article via Infotrieve
  2. 2.↵
    1. Yu EW,
    2. Bouxsein ML,
    3. Roy AE,
    4. Baldwin C,
    5. Cange A,
    6. Neer RM,
    7. et al
    . Bone loss after bariatric surgery: discordant results between dxa and qct bone density. J Bone Miner Res 2014;29:542–50.
    OpenUrlCrossRefPubMed Order article via Infotrieve
View Abstract
PreviousNext
Back to top

In this issue

Clinical Chemistry: 64 (1)
Vol. 64, Issue 1
January 2018
  • Table of Contents
  • About the Cover
  • Index by author
  • Table of Contents (PDF)
  • Cover (PDF)
  • Advertising (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
  • Audio summary of this issue
Print
Share
Commentary
Maya Styner, Nichole Korpi-Steiner
Clinical Chemistry Jan 2018, 64 (1) 51-52; DOI: 10.1373/clinchem.2017.281865
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Commentary
Maya Styner, Nichole Korpi-Steiner
Clinical Chemistry Jan 2018, 64 (1) 51-52; DOI: 10.1373/clinchem.2017.281865

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Footnotes
    • References
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Commentary
  • A Man with Recurrent Fractures and Foot Pain
  • Commentary
Show more Clinical Case Study

Similar Articles

Options

  • Home
  • About
  • Articles
  • Information for Authors
  • Resources
  • Abstracts
  • Submit
  • Contact
  • RSS

Other Publications

  • The Journal of Applied Laboratory Medicine
Footer logo

© 2018 American Association for Clinical Chemistry

Powered by HighWire